Hsp110-STAT3 interaction-IN-2

Hsp110-STAT3 interaction-IN-2

• UNSPSC Description: Hsp110-STAT3 interaction-IN-2 (compound 10b) is a Hsp110-STAT3 interaction disruptor. Hsp110-STAT3 interaction-IN-2 can be used in pulmonary arterial hypertension (PAH) related research[1].
• Target Antigen: HSP; STAT
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage;JAK/STAT Signaling;Metabolic Enzyme/Protease;Stem Cell/Wnt
• Field of Research: Cardiovascular Disease
• Assay Protocol: https://www.medchemexpress.com/hsp110-stat3-interaction-in-2.html
• Smiles: OC1=CC=CC(C2=NC(C3=C(OCC4=CC=CC(C)=C4)N=C(N(C)N=C5C(F)(F)F)C5=C3)=NO2)=C1
• Molecular Weight: 481.43
• References & Citations: [1]Li M, et al. Design, synthesis and optimization of pyrazolo[3,4-b] pyridine derivatives as Hsp110-STAT3 interaction disruptors for the treatment of pulmonary arterial hypertension. Bioorg Chem. 2024 Oct 14;153:107888.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported